Literature DB >> 24568533

Yield and complications of frame-based and frameless stereotactic brain biopsy--the value of intra-operative histological analysis.

Laurent J Livermore1, Ruichong Ma, Stana Bojanic, Erlick A C Pereira.   

Abstract

OBJECTIVES: Image-guided brain biopsy is an established method to obtain histopathological diagnosis and guide management for cerebral lesions. The study aimed to establish negative biopsy and symptomatic haemorrhage rates at a single centre, and to assess the influence of factors such as lesion location, final pathology and the use of intra-operative smears.
METHODS: A retrospective analysis of all frame-based and frameless stereotactic biopsies carried out over 57 months from July 2006 to March 2011.
RESULTS: A total of 351 biopsies were undertaken, 256 frame-based (73%) and 95 frameless (27%). Mean age was 57 years (range 18-87). Negative biopsy rate was 5.1%. There was a significantly greater negative biopsy rate in deep brain biopsies (p = 0.011) and in the cerebellum (p < 0.001). Intra-operative smear significantly reduced negative biopsy rates from 11.1% to 3.7% (p = 0.011). If repeat smear was requested, yet not provided, then the negative biopsy rate was 57.1% (p = 0.0085). The overall symptomatic haemorrhage rate was 3.7%. There was a significant increase in haemorrhage rate in deep versus superficial biopsies (p = 0.023) and a significantly greater haemorrhage rate in lymphoma biopsies (p = 0.015). There was no significant increase in haemorrhage rate in high-grade compared with low-grade tumour biopsies. Mortality rates at 7 and 30 days post-operatively were 0.6% and 1.7%, respectively, with mortality after 7 days unrelated to biopsy.
CONCLUSION: We advocate intra-operative histopathological analysis to decrease negative biopsy rates and advise increased caution when undertaking biopsies of deep lesions or suspected lymphoma cases due to the potentially increased risk of haemorrhage.

Entities:  

Keywords:  brain biopsy; frameless; haemorrhage rate; intra-operative smear; lymphoma

Mesh:

Year:  2014        PMID: 24568533     DOI: 10.3109/02688697.2014.887657

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

1.  Symptomatic intracranial hemorrhages and frame-based stereotactic brain biopsy.

Authors:  Monica Lara-Almunia; Javier Hernandez-Vicente
Journal:  Surg Neurol Int       Date:  2020-08-01

2.  Complications after frame-based stereotactic brain biopsy: a systematic review.

Authors:  Maximilien Riche; Aymeric Amelot; Matthieu Peyre; Laurent Capelle; Alexandre Carpentier; Bertrand Mathon
Journal:  Neurosurg Rev       Date:  2020-01-04       Impact factor: 3.042

3.  O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.

Authors:  Alexander Heinzel; Dirk Müller; Sareh Said Yekta-Michael; Garry Ceccon; Karl-Josef Langen; Felix M Mottaghy; Martin Wiesmann; Martin Kocher; Elke Hattingen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

4.  Endoscopic versus stereotactic biopsies of intracranial lesions involving the ventricles.

Authors:  Marcin Birski; Jacek Furtak; Kamil Krystkiewicz; Julita Birska; Karolina Zielinska; Paweł Sokal; Marcin Rusinek; Dariusz Paczkowski; Lukasz Szylberg; Marek Harat
Journal:  Neurosurg Rev       Date:  2020-08-21       Impact factor: 3.042

5.  Contemporary frameless intracranial biopsy techniques: Might variation in safety and efficacy be expected?

Authors:  Iris S C Verploegh; Victor Volovici; Iain K Haitsma; Joost W Schouten; Clemens M Dirven; Johan M Kros; Ruben Dammers
Journal:  Acta Neurochir (Wien)       Date:  2015-08-29       Impact factor: 2.216

6.  Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios.

Authors:  Ewan Gray; Holly J Butler; Ruth Board; Paul M Brennan; Anthony J Chalmers; Timothy Dawson; John Goodden; Willie Hamilton; Mark G Hegarty; Allan James; Michael D Jenkinson; David Kernick; Elvira Lekka; Laurent J Livermore; Samantha J Mills; Kevin O'Neill; David S Palmer; Babar Vaqas; Matthew J Baker
Journal:  BMJ Open       Date:  2018-05-24       Impact factor: 2.692

7.  Venture in 101 Cranial Punctures: A Comparative Study between Frame-based versus Frameless Biopsy of 101 Intracranial Space Occupying Lesion.

Authors:  Suresh Bishokarma; Pratyush Shrestha; Sagar Koirala; Manita Raut; Dinesh Nath Gongal
Journal:  Asian J Neurosurg       Date:  2019 Jan-Mar

8.  Accuracy of Robotic and Frame-Based Stereotactic Neurosurgery in a Phantom Model.

Authors:  Andrea Spyrantis; Tirza Woebbecke; Daniel Rueß; Anne Constantinescu; Andreas Gierich; Klaus Luyken; Veerle Visser-Vandewalle; Eva Herrmann; Florian Gessler; Marcus Czabanka; Harald Treuer; Maximilian Ruge; Thomas M Freiman
Journal:  Front Neurorobot       Date:  2022-03-25       Impact factor: 3.493

Review 9.  Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.

Authors:  Sanjay Dhawan; Andrew S Venteicher; William E Butler; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2021-07-12       Impact factor: 4.130

10.  Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures.

Authors:  Jan-Oliver Neumann; Benito Campos; Bilal Younes; Martin Jakobs; Christine Jungk; Christopher Beynon; Andreas von Deimling; Andreas Unterberg; Karl Kiening
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.